This article provides educational information based on published research
Abordons ensemble les nuances de la L-Carnitine, pour une utilisation rflchie et bnfique
As GLP1 receptor agonists become more widely prescribed, understanding how this pathway works helps clinicians better tailor treatments for real-world patient challenges
Targets inflammatory actions: Inflammation can result from acne and hyperpigmentation
Acute gallbladder disease In trials for Mounjaro, 0.6% of participants reported gallbladder disease including gallstones, gallbladder inflammation, biliary colic (intermittent or constant abdominal pain), and cholecystectomy (surgical removal of the gallbladder)compared to 0% in the placebo group
Investments are significant in the region, driving rapid product launches, clinical trials for new indications, and early adoption of innovative GLP-1 formulations, including oral and long-acting injectables